Zhao P, Wang W
Department of Ophthalmology, Shanghai Medical University.
Zhonghua Yan Ke Za Zhi. 1995 Jul;31(4):255-8.
Twenty two eyes of 22 cases with severe intraocular fibrin formation after vitrectomy who had been all unresponsive to conventional therapy were treated with tissue plasminogen activator (t-PA), including complicated retinal detachment (14 eyes), intraocular foreign body (3 eyes), vitreous hemorrhage (2 eyes), traumatic cataract (2 eyes) and endophthalmitis (1 eye). The fibrin formation appeared 1-5 days with a mean of 2 days after operation. Of these 22 eyes, fibrin was seen in the pupillary area in 11, in the anterior chamber in 10 eyes and in the vitreous cavity in 1 eye. The initial injection of t-PA was given between the 5th and 15th (mean, 8.6 days) postoperative days after vitrectomy. The t-PA (5-30 micrograms) was injected into the anterior chamber in 21 cases and into the vitreous cavity in 1 case (25 micrograms). Once injection resulted in complete fibrinolysis in 19 of 22 eyes and partial fibrinolysis in 3 eyes, and the complete dissolution with one injection was achieved within 0.5-2.5 hours with a mean of 1 hour. 1 eye required repeated t-PA injection for recurrent fibrin formation and the repeated injection resulted in complete fibrinolysis in this case. The follow-up periods ranged from 1 to 20 months (mean period, 10 months). At the final follow-up examination, the retina was totally attached in 16 of 22 eyes and partially attached and detached in 6. Visual acuity improved in 13 eyes. Complications of t-PA injection included hyphema, elevated intraocular pressure (IOP) and hyphema with elevated IOP in 1 case respectively. Factors affecting the therapeutic effect of t-PA and methods preventing the complications of t-PA injection were discussed.
22例玻璃体切除术后发生严重眼内纤维蛋白形成且对传统治疗均无效的患者共22只眼,接受了组织型纤溶酶原激活剂(t-PA)治疗,其中包括复杂性视网膜脱离(14只眼)、眼内异物(3只眼)、玻璃体积血(2只眼)、外伤性白内障(2只眼)和眼内炎(1只眼)。纤维蛋白形成出现在术后1 - 5天,平均为术后2天。在这22只眼中,11只眼的纤维蛋白出现在瞳孔区,10只眼出现在前房,1只眼出现在玻璃体腔。t-PA的首次注射在玻璃体切除术后第5至15天(平均8.6天)进行。21例将t-PA(5 - 30微克)注入前房,1例(25微克)注入玻璃体腔。一次注射使22只眼中的19只眼纤维蛋白完全溶解,3只眼部分溶解,一次注射完全溶解在0.5 - 2.5小时内完成,平均为1小时。1只眼因纤维蛋白反复形成需要重复注射t-PA,重复注射后该眼纤维蛋白完全溶解。随访时间为1至20个月(平均10个月)。在最后一次随访检查时,22只眼中16只眼视网膜完全附着,6只眼部分附着或脱离。13只眼视力提高。t-PA注射的并发症分别包括1例前房积血、1例眼压升高和1例前房积血合并眼压升高。讨论了影响t-PA治疗效果的因素及预防t-PA注射并发症的方法。